1)日本産婦人科学会(編・監),他:産婦人科診療ガイドライン—婦人科外来編2020. pp64-65,日本産婦人科学会,2020.
2)Bryant-Smith AC, et al : Antifibrinolytics for heavy menstrual bleeding. Cochrane Database of Syst Rev 4(4) : CD000249, 2018. PMID 29656433
3)Grigorieva V, et al : Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 79(5) : 1194-1198, 2003. PMID 12738516
4)Lethaby A, et al : Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2 : CD000547, 2001. PMID 11405968
5)Tanaka T:Effects of herbal medicines on menopausal symptoms induced by gonadotropin-releasing hormone agonist therapy. Clin Exp Obstet Gynecol 28(1) : 20-23, 2001. PMID 11332582
6)Sakamoto S, et al : Pharmacotherapeutic effects of Kuei-chih-fu-ling-wan(Keishi-bukuryo-gan)on human uterine myomas. Am J Chin Med 20(3-4) : 313-317, 1992. PMID 1471615
7)Scheurig-Muenkler C, et al : Radiation exposure during uterine artery embolization ; effective measures to minimize dose to the patient. J VascIntervRadiol 24 : 765-771, 2013. PMID 25148920